The future of phage therapy is closely tied to advances in genomics, precision medicine, and antimicrobial research. As antibiotic resistance continues to rise globally, bacteriophages offer a highly targeted and adaptable approach to treating bacterial infections. Improved bacterial diagnostics and genome sequencing now allow scientists to rapidly match specific phages to specific pathogens, paving the way for personalized phage therapies.

In addition, the development of phage cocktails and engineered phages is increasing treatment effectiveness while reducing the likelihood of bacterial resistance.Looking ahead, stronger regulatory frameworks, increased clinical trials, and international collaboration will be key to mainstreaming phage therapy into modern healthcare systems.

Beyond human medicine, phage therapy is expected to play an important role in veterinary medicine, agriculture, food safety, and environmental health. With continued scientific investment and policy support, phage therapy has the potential to become a cornerstone of sustainable infection control and a powerful complement to traditional antibiotics in the fight against resistant bacteria.